Implementation of step-and-shoot intensity-modulated radiotherapy (IMRT) needs careful understanding of the accelerator start-up characteristic to ensure accurate and precise delivery of radiation dose to patient. The dosimetric characteristic of a Siemens Primus linear accelerator (LA) which delivers 6 and 18 MV x-rays at the dose rate of 300 and 500 monitor unit (MU) per minutes (min) respectively was studied under the condition of small MU ranging from 1 to 100. Dose monitor linearity was studied at different dose calibration parameter (D1_C0) by measuring ionization at 10 cm depth in a solid water phantom using a 0.6 cc ionization chamber. Monitor unit stability was studied from different intensity modulated (IM) groups comprising various combinations of MU per field and number of fields. Stability of beam flatness and symmetry was investigated under normal and IMRT mode for 20×20 cm2 field under small MU using a 2D Profiler kept isocentrically at 5 cm depth. Inter segment response was investigated form 1 to 10 MU by measuring the dose per MU from various IM groups, each consisting of four segments with inter-segment separation of 2 cm.In the range 1-4 MU, the dose linearity error was more than 5% (max −32% at 1 MU) for 6 MV x-rays at factory calibrated D1_C0 value of 6000. The dose linearity error was reduced to −10.95% at 1 MU, within −3% for 2 and 3 MU and ±1% for MU ≥4 when the D1_C0 was subsequently tuned at 4500. For 18 MV x-rays, the dose linearity error at factory calibrated D1_C0 value of 4400 was within ±1% for MU ≥3 with maximum of −13.5 observed at 1 MU. For both the beam energies and MU/field ≥4, the stability of monitor unit tested for different IM groups was within ±1% of the dose from the normal treatment field. This variation increases to −2.6% for 6 MV and −2.7% for 18 MV x-rays for 2 MU/field. No significant variation was observed in the stability of beam profile measured from normal and IMRT mode. The beam flatness was within 3% for 6 MV x-rays and more than 3% (Max 3.5%) for 18 MV x-rays at lesser irradiation time ≤3 MU. The beam stability improves with the increase in irradiation time. Both the beam energies show very good symmetry (≤2%) at all irradiation time.For all the three segment sizes studied, the nonlinearity was observed at smaller MU/segment in both the energies. When the MU/segment is ≥4, all segment size shows fairly linear relation with dose/MU. The smaller segment size shows larger nonlinearity at smaller MU/segment and become more linear at larger MU/segment. Based on our study, we conclude that the Primus LA from Siemens installed at our hospital is ideally suited for step-and-shoot IMRT preferably for radiation ON time ≥4MU per segment.
In the present work, mesoporous titania (MT)-embedded polyacrylonitrile (PAN) nanofibrous membranes have been developed and studied for their efficiency in particulate matter (PM) filtration. Using Box–Behnken method, 15 nanofibrous composite membranes were obtained through electrospinning by choosing three different process variables, such as MT (weight ratio), areal density (g m−2), and spinning time (h). The characterization of resulted nanofibrous composite membranes revealed that the homogenous distribution of MT (2.9 nm) within the PAN delivers high porosity as well as air permeability. Further, filtration efficiency (FE) was also analyzed for PM from 0.3 µm to 3 µm. PM filtration studies suggested that the nanofibrous composite membrane developed from 15% MT, spin time of 2 h, and areal density of 80 g m−2 possesses overall efficiency of 96.4%, without pressure drop for the composite. The results suggest that the role of MT was found to be significant in achieving successful filtration of PM. In addition to successful FE, the desirability value of the developed composite was also calculated statistically and the optimized composite membrane was identified.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.